Frequently Asked Questions (FAQs)/Updates
8.15.25
Anticipated transaction closing sometime in Q4 2025.
6.18.25
Summa Health has received regulatory approval from the Ohio Department of Insurance as well as approval from the Ohio Attorney General's office to proceed with our transaction, subject to the satisfaction of certain conditions.
These are significant milestones as we work toward the completion of our transaction with HATCo. With these two crucial regulatory approvals now received, we will continue to focus on completing all of the remaining details necessary to finalize the transaction, including the legal work required to meet the conditions developed by the Attorney General’s office and receipt of all other required regulatory approvals.
We look forward to sharing additional details as they become available, including a more specific timeline around the anticipated closing of the transaction, when our two organizations officially move forward together to begin to advance our long-term vision to create a new, more proactive, affordable and equitable system of community-based, lifelong healthcare.
4.25.25
Are Summa Health leaders receiving retention agreements related to the transaction with HATCo? Are these agreements structured to incentivize leaders to close the deal?
The Summa Health Board of Directors in exercising its fiduciary responsibilities has made the decision to enter into a definitive agreement with HATCo to create a new, more proactive, affordable and equitable system of community-based, lifelong healthcare. The Board is comprised of volunteers who are not compensated for their service to the Board and have not and will not receive any compensation or incentives from either Summa or HATCo as part of our proposed transaction.
The Board is committed to ensuring steady and consistent leadership as we continue advancing the long-term journey to bolster Summa Health’s existing strengths, drive accelerated growth, continue advancing our mission, and reshape and improve the future of healthcare delivery.
The Summa Health Board has issued retention agreements to some Summa Health employees to help ensure stability and continuity during the ongoing transaction process with HATCo. While some retention milestones are tied to phases of the transaction, these agreements are not structured to incentivize closing the transaction; rather, they recognize our employees’ long-standing commitment and ongoing responsibilities as they guide the organization through anticipated transformation.
Retention agreements are a common and prudent practice in times of organizational change and often used by not-for-profit organizations. Consistent leadership is critical to maintaining high-quality care, effective operations, and a successful integration process, should the transaction receive full regulatory approval.
The Board’s decision to issue retention agreements was informed by an external advisor that specializes in compensation and provided guidance on the market appropriateness of the retention agreements and issued a fair market opinion to the Board. In addition, details on retention agreements were included in Summa Health’s regulatory review submissions. Our leadership team remains committed to making decisions that are in the best interest of Summa Health, our patients, employees, and the communities we serve.
11.7.24
What is a Definitive Agreement?
What are the strategic priorities for Summa Health and HATCo in the transition period and first year after the acquisition closes?
What is the total investment that HATCo is making in Summa Health?
The purchase price of $485 million, when added to Summa Health’s current cash, will enable the health system to eliminate $850 million in existing debt. The remaining cash, after closing adjustments, will fund a new, separately governed community foundation that will support focused investment to benefit community health in the Greater Akron region.
After the transaction closes, HATCo will make a long-term capital commitment for Summa Health’s continued operations. This includes $350 million in capital funding within the first five years to ensure the necessary resources are available for routine purposes, and investment in technologies that support growth. This commitment is not dependent upon performance and is approximately 25% higher than Summa Health’s current annual capital spend.
HATCo’s long-term support includes an additional $200 million over the first seven years that is intended for strategic and transformative investments and to drive innovation, which will be more fully defined as Summa Health transitions into its new model and through a stabilization phase.
Importantly, the final investments made through HATCo’s acquisition of Summa Health are subject to regulatory reviews and approvals by the Ohio Attorney General, the Ohio Department of Insurance, the Federal Trade Commission and all other applicable regulatory bodies.
How much will HATCo invest into the new community foundation?
The new community foundation will be created through a process that is independent from the transaction and will be governed separately from HATCo and the health system after the closing of the transaction. Both HATCo and Summa are committed to complying with this legal requirement and are taking all steps to respect this process.
How was the new foundation established? Who served on the Board/Committee that created the guidelines for the new foundation?
The new community foundation will be created through a process that is independent from the transaction and will be governed separately from HATCo and the health system following the closing. Both HATCo and Summa are committed to complying with this legal requirement and are taking all steps to respect this process.
Importantly, the creation of the new foundation is part of the Definitive Agreement sent to the Ohio Attorney General for regulatory review. This submission includes details on the proposed structure, charter, governance and purpose. With full regulatory approval, the new foundation will be established and begin its important work for the community.
When will the new foundation be operational – will it be established in tandem with the completion and close of the acquisition?
What occurs during the regulatory process and why are approvals necessary to proceed? What state and federal parties are involved in reviewing and approving the Definitive Agreement?
All regulatory bodies will take the time they need to thoroughly review the proposed acquisition. Regulatory review is an important step in the process. Once we have completed all regulatory requirements, we will be able to share more detailed information about the path forward.
What happens after regulatory approval?
We are collectively establishing a comprehensive plan that includes a stabilization period during which will focus on operationally stabilizing the organization, which is an extension of our ongoing work during the past few years.
Following stabilization, we will move into a transformation phase together. Planning for this market transformation is very high level right now, and we want the broader organization involved when vetting ideas. We will be able to talk more about the phases of this work and how to get involved once we have received full regulatory approval and closed the acquisition with HATCo.
What is the timeline for the acquisition to close? When will the final decision be made?
1.17.24
What is the status of the Summa Health/HATCo relationship?
Why is Summa Health pursuing this relationship with HATCo?
Becoming part of HATCo positions our leadership, providers and employees for continued success and will build on and enhance the quality of care provided to our patients in the Greater Akron region and across Northeast Ohio. The HATCo promise of Health Assurance mirrors our promise to always provide everyone we serve with access to quality care.
Who is HATCo?
In collaboration with health system and technology leaders through partnerships, investments, and acquisitions, HATCo seeks to drive efficiency, affordability, and transparency to transform the healthcare industry to be more proactive, resilient, and equitable for communities and society. The HATCo platform is designed to combine the best leadership and capabilities in healthcare and tech to inform, support and drive transformation enablement while addressing system fragmentation and improving access to – and quality of – care.
HATCo brings significant healthcare experience and a leadership team headed by Dr. Marc Harrison. Dr. Harrison is a pediatric critical care physician, global healthcare leader, and former president and CEO of Intermountain Healthcare. He joined General Catalyst to launch HATCo with Hemant Taneja and lead it as CEO with the mission to deliver health and wellness collaboratively, compassionately, and courageously – for all people.
HATCo is capitalized outside of General Catalyst’s venture funds; it has its own leadership team led by CEO Dr. Marc Harrison; and it has a clear and distinctive charter: 1) to work with our health system partners to help them develop and execute their transformation journey; 2) to help catalyze the health assurance ecosystem, building an interoperability model with technology solutions including a subset of our health care portfolio companies to drive this transformation; and 3) to acquire and operate a health system for the long term where we can demonstrate the blueprint of this transformation for the rest of the industry.
Why is HATCo interested in Summa Health?
Both organizations recognize the challenges inherent in the current business model for not-for-profit healthcare and are excited about this opportunity to not only build on Summa Health’s existing strengths but truly accelerate innovative change in healthcare delivery.
How will this partnership impact the work Summa Health has been doing across the organization and community?
We believe our relationship with HATCo will support our continued success and strengthen the key areas of focus in our current strategic plan: Investing in Our People, Creating One Summa Experience, Expanding the Continuum and Pursuing Regionalization.
This new structure will leverage both organizations’ strengths and aims to create a sustainable, innovative path forward to better serve Summa Health’s communities clinically, economically, and socially by:
- Providing long-term financial stability;
- Investing in local health care and expanding and advancing our programs and services;
- Expanding the growth of SummaCare to advance health equity and population health;
- Supporting continued investment in our communities’ health care needs;
- Prioritizing the professional futures of our employees and medical staff;
- Creating an enhanced pipeline for recruitment and innovation;
- Building upon our commitment to medical education and training physicians to care for tomorrow’s patients and communities; and
- Introducing new resources, innovation and technologies not currently available to the organization, including in the areas of employee engagement and information technology.
How will this partnership affect patients?
Will Summa Health’s current services remain intact?
Will this relationship negatively impact the cost or quality of healthcare in our region?
Will Summa Health facilities continue to accept the same insurance/networks? What about Medicaid and Medicare?
Will the Summa Health name and logo remain?
How will this partnership impact SummaCare?
We anticipate no disruption to our SummaCare customers or members. In fact, we expect that our strategic alignment with HATCo will create new opportunities to further strengthen and expand SummaCare.
How will this relationship impact employees?
HATCo supports and is committed to continued investment in our employees and providers who have created and supported Summa Health’s success. Investing in Our People remains a critical area of focus across the organization and we will continue to:
- Prioritize short and long-term workforce development.
- Promote diversity, equity and inclusion.
- Enhance employee and clinician engagement.
- Expand quality, safety and nursing infrastructures.
Together, Summa Health and HATCo will examine all opportunities to implement strategies that prioritize the professional futures of all our valued employees and providers.
Summa Health is proud to have strong physician leadership across the organization. Will this change as Summa Health becomes part of HATCo?
Dr. Cliff Deveny, the Summa Health leadership team, and physician leaders across the organization will collaborate closely with Dr. Marc Harrison, a pediatric critical care physician and former president and CEO of Intermountain Healthcare, and the HATCo team. Together we will build on our strengths and collaboratively shape a transformative journey – not overhaul our organization.
Will this relationship with HATCo impact medical education or Summa Health’s commitment to residents?
Both Summa Health and HATCo share a belief that teaching the next generation of providers is critical to the health and wellness of the people we serve. Graduate medical education will continue to be a priority at Summa Health.
Will this new structure and ownership by HATCo impact or change the culture of Summa Health?
Summa Health’s leadership team, in partnership with Dr. Marc Harrison and the HATCo team, are committed to continued investment in our employees and providers who have driven and supported Summa Health’s success.
Will Summa Health become a for-profit organization as a result of this strategic relationship?
Will the Summa Health Foundation remain intact?
How will a new community foundation support the Greater Akron region?
How will the anticipated proceeds from this transaction be paid to charity care and community benefit moving forward?
Summa Health has been proud to increase its investment in community benefit year over year – including $210 million in community impact in 2022, with $11.5 million specifically allocated to charity care – and will continue to do so with HATCo’s full support.
Where will donors’ investment be allocated, once the current Summa Health Foundation is restructured?
Will Summa Health no longer be tax-exempt when it becomes part of a for-profit organization? When will this begin? How much does Summa Health anticipate paying in state and federal taxes each year?
Will Summa Health’s revenue remain within the community after it becomes part of HATCo?
Summa Health will also begin to pay taxes within the new for-profit structure, providing additional economic benefit to our region through enhanced revenue that is invested back into the communities we serve.
Will becoming part of HATCo realign Summa Health’s incentives to be more consistent with a typical for-profit model?
This strategic relationship is based on shared success. While Summa Health will benefit from the investment, technology and innovation that HATCo provides, HATCo will only achieve its ultimate goal of transforming healthcare if Summa Health thrives as a health system that continues to deliver high-quality care and population health to its patients and communities.
Is Summa Health in a financial hardship?
However, we recognize that pressures like rising supply costs and ongoing changes in reimbursement will continue to negatively impact our bottom line and ability to serve patients and staff. In our current structure, we will have limited ability to continue investing in the growth and improvements our community deserves and needs.
This strategic alignment with and investment from HATCo is an opportunity to further strengthen and bolster Summa Health’s existing strengths, drive accelerated growth and continue advancing our mission.
There have been many media stories outlining the negative impact private equity ownership has on hospital safety and quality. How will this be different?
The Summa Health Board and leadership team have confidence in this shared vision and in HATCo’s leadership team, led by Dr. Marc Harrison. Both Dr. Deveny and Dr. Harrison have spent their careers leading and serving large healthcare systems and have proven experience putting patients and communities at the center of decision-making.
While this is an acquisition, both organizations are committed to creating a meaningful, collaborative relationship with one another on a long-term journey to reshape and improve the future of healthcare delivery.
Although we understand the concerns about being backed by venture capital, we believe that in HATCo, we have found a truly strategic partner that is committed to our model and the culture that has driven Summa Health’s success.
Why not simply partner with another healthcare organization?
Upon meeting the HATCo team, it became clear that our two organizations are very much aligned in our vision for the future of healthcare. As those conversations continued and we got to better know each other’s visions and capabilities, it became clear that partnering with HATCo provides us with comprehensive opportunities to transform our organization in ways that we can’t achieve alone and that simply aren’t available by partnering with another healthcare organization navigating the same industry challenges we face.
We are confident that it is the best opportunity to continue expanding access to – and delivering – health and wellness collaboratively, compassionately, and courageously for all people.
What will happen during the due diligence period?
Summa Health’s current and planned commitments will continue to proceed, and the organization will continue to invest in Ohio employees and initiatives. Summa Health will continue to provide the same essential services it currently offers, with a focus on continued growth and enhanced access to care.